| Name | Title | Contact Details |
|---|---|---|
Laura Rigby |
SVP of Finance and Analytics | Profile |
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
We never stop striving for a better future. A true passion for improving patient lives. Medical education - The surgeon is never alone.
Quality Dispensing Pharmacy, Inc. is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Checkpoint Surgical advances the science and practice of nerve protection and repair to improve the quality of life for patients and physicians.